Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
Launched by NORTHWESTERN UNIVERSITY · Jun 13, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to measure blood pressure in pregnant women, especially those who are overweight or obese. It compares two types of blood pressure cuffs: a conical cuff that fits the forearm and a cylindrical cuff that fits the upper arm. The goal is to see if the conical cuff can provide more accurate blood pressure readings. Accurate blood pressure measurement is very important during pregnancy because high blood pressure can lead to serious conditions like gestational hypertension or preeclampsia. If the conical cuff is proven to be more reliable, it could help doctors make better decisions about treatment, reducing unnecessary interventions like early delivery or cesarean sections.
Women who are 18 years or older and have a body mass index (BMI) of 20 or higher may be eligible to participate. They should be coming to the hospital for labor and delivery, whether or not they have been diagnosed with high blood pressure during pregnancy. Participants will have their blood pressure measured using both types of cuffs, and the researchers will compare the results to see how well they match. This trial aims to improve care for the many pregnant women facing these health challenges, making it easier for doctors to manage their pregnancies safely.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women who are 18 years of age or older with a
- • Body mass index (BMI) of 20 kg/m2 or greater
- • Present to Labor and Delivery with or without a diagnosis of gestational hypertension, preeclampsia, or chronic hypertension with super-imposed preeclampsia, in spontaneous labor or for induction of labor
- Exclusion Criteria:
- • Significant peripheral arterial disease resulting in at least a 10 mm Hg blood pressure difference between both arms
- • History of repaired or unrepaired congenital heart disease
- • History of significant arrythmia
- • History of pacemaker or implantable cardioverter defibrillator placement
- • History of sickle cell disease
- • History of Raynaud's phenomenon on any extremity
- • History of lymph node dissection of either upper extremity
- • Patients who are less than 18 years of age
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Adithya Bhat, MD
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported